Sarah Reiter - 08 Jun 2021 Form 4 Insider Report for Calyxt, Inc. (CBUS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Jun 2021, 16:53:44 UTC
Prior SEC filing
10 May 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Suzette McNally, Attorney-in-Fact for Sarah Reiter

Key filing fact

Sarah Reiter filed Form 4 for Calyxt, Inc. (CBUS) on 10 Jun 2021.

Key facts

  • This page summarizes Sarah Reiter's Form 4 filing for Calyxt, Inc. (CBUS).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 10 Jun 2021, 16:53.

Change

  • Previous filing in this sequence was filed on 10 May 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CBUS transaction

Common Stock

Award

Transaction value
$0
Shares
+11,601
Change %
+122%
Price
$0.000000
Shares after
21,101
Date
08 Jun 2021
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CBUS transaction Derivative

Stock Option (Right-to-Buy)

Award

Transaction value
$0
Shares
+16,573
Change %
Price
$0.000000
Shares after
16,573
Date
08 Jun 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
16,573
Exercise price
$4.54
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Restricted Stock Units vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant.

Footnote F2

Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .